Skip to main content
Cytophage Technologies Ltd. logo

Cytophage Technologies Ltd. — Investor Relations & Filings

Ticker · CYTO ISIN · CA2328211081 LEI · 254900L9XZT97QIBN831 TSXV Professional, scientific and technical activities
Open in API
Filings indexed 70 across all filing types
Latest filing 2026-04-15 Board/Management Inform…
Country CA Canada
Listing TSXV CYTO

About Cytophage Technologies Ltd.

https://cytophage.com/

Cytophage Technologies Ltd. is a pioneering biotechnology company focused on developing synthetic bacteriophage products to prevent and treat bacterial infections, aiming to reduce and ultimately replace the use of conventional antibiotics. The company utilizes molecular genetic techniques and proprietary synthetic biology technology to create tailor-made, highly effective phages that are harmless to humans and animals. Cytophage's solutions address three primary markets: Animal Health (e.g., livestock illness prevention and growth enhancement), Food Safety (preventing disease spread without antibiotics), and Human Health (treating bacterial illnesses and hospital decontamination). A key competitive advantage is the rapid production timeline for targeted phages, enabling quick response to bacterial threats. The company is also engaged in advanced research, including the development of genetically engineered phage-based vaccines.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Board/Management Information Classification · 1% confidence The document is a press release announcing the departure of the company’s Chief Operating Officer, a senior management change. This fits the ‘Board/Management Information’ category for changes in senior management.
2026-04-15 English
News release - English.pdf
Board/Management Information Classification · 1% confidence The document is a corporate press release announcing the departure of the company’s Chief Operating Officer as part of a restructuring. This constitutes a management change announcement, fitting the Board/Management Information category.
2026-04-15 English
News release - English.pdf
Board/Management Information Classification · 1% confidence The document is a press release announcing the departure of the company’s Chief Operating Officer and describing a corporate restructuring. This is a management change notice, fitting the category for Board/Management Information. It is not a full report, earnings release, or other regulatory filing, but specifically an announcement of a senior management change.
2026-04-15 English
News release - English.pdf
Board/Management Information Classification · 1% confidence The document is a press release announcing the departure of the Chief Operating Officer and refers to a corporate restructuring and board oversight. It is an announcement of a change in senior management. Therefore it fits the Board/Management Information category.
2026-04-15 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is a 'Form 45-106F1 Report of Exempt Distribution', which is a standard Canadian regulatory filing used to report the sale of securities under prospectus exemptions. This document details the distribution of securities (units consisting of common shares and warrants), the amount raised, and the exemptions relied upon. Since it is a specific regulatory filing for capital distribution that does not fit into the other categories like 10-K, IR, or ER, it falls under the 'Regulatory Filings' category.
2025-12-08 English
News release - English.pdf
Report Publication Announcement Classification · 1% confidence The document is a press release announcing two primary events: the closing of a non-brokered private placement (capital raising) and the filing of the company's Q3 financial results. According to the 'Menu vs Meal' rule, since the document is a short announcement that directs readers to an external source (SEDAR+) to view the actual financial reports, it is classified as a Report Publication Announcement (RPA). While it contains details about a private placement, the primary purpose of the release is to announce the completion of these corporate actions and the availability of the financial filings.
2025-11-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.